Expression of ferroportin1, hephaestin and ceruloplasmin in rat heart

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 5, 2007, Pages 527-532

  Qian, Zhong Ming ^a,c   Chang, Yan Zhong ^a   Leung, Gina ^a   Du, Jun Rong ^a   Zhu, Li ^a,c   Wang, Qin ^a   Niu, Lijian ^a   Xu, You Jia ^a   Yang, Lei ^a   Ho, Kwok Ping ^a   Ke, Ya ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c NANTONG UNIVERSITY   (China)

Author keywords

Ceruloplasmin; Ferroportin1; Heart; Hephaestin; Iron metabolism; Transferrin receptor

Indexed keywords

CALCIUM CHANNEL L TYPE; CERULOPLASMIN; FERROPORTIN 1; HEPHAESTIN; IRON; IRON BINDING PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIETARY INTAKE; GENE EXPRESSION; HEART; HEART DISEASE; HEART LEFT VENTRICLE; HEART MUSCLE; IRON DEFICIENCY; IRON OVERLOAD; IRON TRANSPORT; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CATION TRANSPORT PROTEINS; CERULOPLASMIN; IRON; MALE; MEMBRANE PROTEINS; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFERRIN; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

RATTUS;

EID: 34247242656     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.02.006     Document Type: Article

References (48)

1. Berenshtein E., Mayer B., Goldberg C., Kitrossky N., and Chevion M. Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury. J. Mol. Cell Cardiol. 29 (1997) 3025-3034
2. Chen Y.Y., Ho K.P., Xia Q., and Qian Z.M. Hydrogen peroxide enhances iron-induced injury in isolated heart and ventricular cardiomyocyte in rats. Mol. Cell. Biochem. 231 (2002) 61-68
3. Klipstein-Grobusch K., Koster J.F., Grobbee D.E., Lindemans J., Boeing H., Hofman A., and Witteman J.C. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 69 (1999) 1231-1236
4. Tuomainen T.P., Punnonen K., Nyyssonen K., and Salonen J.T. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97 (1998) 1461-1466
5. Tzonou A., Lagiou P., Trichopoulou A., Tsoutsos V., and Trichopoulos D. Dietary iron and coronary heart disease risk: a study from Greece. Am. J. Epidemiol. 147 (1998) 161-166
6. Minotti G., Recalcati S., Mordente A., Liberi G., Calafiore A.M., Mancuso C., Preziosi P., and Cairo G. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J. 12 (1998) 541-552
7. Minotti G., Cairo G., and Monti E. Role of iron in anthracycline cardiotoxicity: new tunes for an old song?. FASEB J. 13 (1999) 199-212
8. Xu M.F., Ho S., Qian Z.M., and Tang P.L. Melatonin protects against cardiac toxicity of doxorubicin in rat. J. Pineal. Res. 31 (2001) 301-307
9. Zaman A.K., Fujii S., Sawa H., Goto D., Ishimori N., Watano K., Kaneko T., Furumoto T., Sugawara T., Sakuma I., Kitabatake A., and Sobel B.E. Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice. Circulation 103 (2001) 3123-3128
10. Pereira A.C., Cuoco M.A., Mota G.F., da Silva F.F., Freitas H.F., Bocchi E.A., Soler J.M., Mansur A.J., and Krieger J.E. Hemochromatosis gene variants in patients with cardiomyopathy. Am. J. Cardiol. 88 (2001) 388-391
11. Sullivan J.L., and Zacharski L.R. Hereditary haemochromatosis and the hypothesis that iron depletion protects against ischemic heart disease. Eur. J. Clin. Invest. 31 (2001) 375-377
12. Aessopos A., Farmakis D., Karagiorga M., Voskaridou E., Loutradi A., Hatziliami A., Joussef J., Rombos J., and Loukopoulos D. Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 97 (2001) 3411-3416
13. Duffy S.J., Keaney Jr. J.F., Holbrook M., Gokce N., Swerdloff P.L., Frei B., and Vita J.A. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104 (2001) 151-156
14. Horwitz L.D., and Rosenthal E.A. Iron-mediated cardiovascular injury. Vasc. Med. 4 (1999) 93-99
15. Horwitz L.D., Sherman N.A., Kong Y., Pike A.W., Gobin J., Fennessey P.V., and Horwitz M.A. Lipophilic siderophores of mycobacterium tuberculosis prevent cardiac reperfusion injury. Proc. Nat. Acad. Sci. U. S. A. 95 (1998) 5263-5268
16. Taher A., Sheikh-Taha M., Koussa S., Inati A., Neeman R., and Mourad F. Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients. Eur. J. Haematol. 67 (2001) 30-34
17. Qian Z.M., and Tang P.L. Mechanisms of iron uptake by mammalian cells. Biochim. Biophys. Acta 1269 (1995) 205-214
18. Qian Z.M., Tang P.L., and Wang Q. Iron crosses the endosomal membrane by a carrier-mediated process. Prog. Biophys. Mol. Biol. 67 (1997) 1-15
19. Qian Z.M., and Wang Q. Expression of iron transport proteins and excessive iron accumulation of iron in the brain in neurodegenerative disorders. Brain Res. Rev. 127 (1998) 257-267
20. Hentze M.W., and Kuhn L.C. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 8175-8182
21. Klausner R.D., Rouault T.A., and Harford J.B. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72 (1993) 19-28
22. Link G., Pinson A., and Hershko C. Heart cells in culture: a model of myocardial iron overload and chelation. J. Lab. Clin. Med. 106 (1985) 147-153
23. Ke Y., Chan Y.Y., Zhang Y.Z., .Duan X.L., Ho H.P., Jiang D.H., Wang K., and Qian Z.M. Post-transcriptional expression of DMT1 in the heart of rat. J. Cell Physiol. 196 (2003) 124-130
24. 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat. Med. 9 (2003) 1187-1194
25. Oudit G.Y., Trivieri M.G., Neelam K., Taneya H., Wilson G.J., Liu P., Sole M.J., and Backx P.H. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation 109 (2004) 1877-1885
26. Tsushima R.G., Wickenden A.D., Bouchard R.A., Oudit G.Y., Liu P.P., and Backx P.H. Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ. Res. 84 (1999) 1302-1309
27. Hahn P., Qian Y., Dentchev T., Chen L., Beard J., Harris Z.L., and Dunaief J.L. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13850-13855
28. Harris Z.L., Durley A.P., Tsz K.M., and Gitlin J.D. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10812-10817
29. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J., Paw B.H., Drejer A., Barut B., Zapata A., Law T.C., Brugnara C., Lux S.E., Pinkus G..S., Pinkus J.L., Kingsley P.D., Palis J., Fleming M.D., Andrews N.C., and Zon L.I. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403 (2000) 776-781
30. Vulpe C.D., Kuo Y.M., Murphy T.L., Cowley L., Askwith C., Libina N., Gitschier J., and Anderson G.J. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21 (1999) 195-199
31. Ke Y., and Qian Z.M. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol. 2 (2003) 246-253
32. Qian Z.M., and Shen X. Brain iron transport and neurodegeneration. Trend Mol. Med. 7 (2001) 103-108
33. Qian Z.M., Xiao D.S., Tang P.L., Yao F.Y.D., and Liao Q.K. The increased expression of transferrin receptor on the membrane of erythroblast in strenuous exercised rats. J. Appl. Physiol. 87 (1999) 523-529
34. Qian Z.M., Xiao D.S., Ke Y., and Liao Q.K. Increased nitric oxide is one of the causes of changes of iron metabolism in strenuously exercised rats. Am. J. Physiol. 280 (2001) R739-R743
35. Mukhopadhyay C.K., Attieh Z.K., and Fox P.L. Role of ceruloplasmin in cellular iron uptake. Science 279 (1998) 714-717
36. Mukhopadhyay C.K., Mazumder B., and Fox P.L. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem. 275 (2000) 21048-21054
37. Abboud S., and Haile D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275 (2000) 19906-19912
38. McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., Miret S., Bomford A., Peters T.J., Farzaneh F., Hediger M.A., Hentze M.W., and Simpson R.J. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5 (2000) 299-309
39. Lymboussaki A., Pignatti E., Montosi G., Garuti C., Haile D.J., and Pietrangelo A. The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression. J. Hepatol. 39 (2003) 710-715
40. Martini L.A., Tchack L., and Wood R.J. Iron treatment downregulates DMT1 and IREG1 mRNA expression in Caco-2 cells. J. Nutr. 132 (2002) 693-696
41. Knutson M.D., Vafa M.R., Haile D.J., and Wessling-Resnick M. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102 (2003) 4191-4817
42. Yang F., Wang X., Haile D.J., Piantadosi C.A., and Ghio A.J. Iron increases expression of iron-export protein MTP1 in lung cells. Am. J. Physiol. 283 (2002) L932-L939
43. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., and Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8780-8785
44. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 5704 (2004) 2090-2093
45. Frazer D.M., Vulpe C.D., McKie A.T., Wilkins S.J., Trinder D., Cleghorn G.J., and Anderson G.J. Cloning and gastrointestinal expression of rat hephaestin: relationship to other iron transport proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001) G931-G939
46. Anderson G.J., and Frazer D.M. Recent advances in intestinal iron transport. Curr. Gastroenterol. Rep. 7 (2005) 365-372
47. Anderson G.J., Frazer D.M., McKie A.T., and Vulpe C.D. The ceruloplasmin homolog hephaestin and the control of intestinal iron absorption. Blood Cells Mol. Dis. 29 (2002) 367-375
48. Qian Z.M., Li H., Sun H., and Ho K.P. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54 (2002) 561-587